ARCHIVES

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

This article is from The Cancer Letter archive.

Vol. 35 No. 13 | April 3, 2009

Download PDF Visit The Full Archive

Related Articles

DRCCA Completes New Cancer control Research Guidelines

August 5, 1983

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

July 30, 2004

In Brief: NCI Award 14 Contracts to Operate The Cancer Information Service

August 13, 1999

Army Plans Solicitation For Breast Cancer Research Proposals

April 21, 1995

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

CMS Removes Obstacles for Contractors to Deny EPO Coverage for Cancer Anemia.

March 9, 2007